Exercise Controls Tumor Cell Growth Through AMPK Activation

This study is currently recruiting participants.
Verified November 2013 by Rigshospitalet, Denmark
Sponsor:
Information provided by (Responsible Party):
Inge Holm, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01376583
First received: June 16, 2011
Last updated: November 28, 2013
Last verified: November 2013
  Purpose

The study investigates the explanation for the positive relation found between exercise and breastcancer.


Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Running From Cancer

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Biospecimen Retention:   Samples Without DNA

Bloodsamples wherefrom, serum is isolated and kept at -20 degrees celsius


Estimated Enrollment: 10
Study Start Date: March 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 30 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy Danish females in the age 18-30

Criteria

Inclusion Criteria:

  • Healthy Females age 18-30
  • BMI 18-25
  • Regular period

Exclusion Criteria:

  • Ingestions of any hormones
  • Pregnancy
  • Chronic inflammation
  • Elite athletes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01376583

Locations
Denmark
Centre of Inflammation and Metabolism Recruiting
Copenhagen, Denmark, 2100
Contact: Grith W Højfeldt, BSc       grithwh@hotmail.com   
Principal Investigator: Grith W Højfeldt, BSc         
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Study Director: Bente K Pedersen, Professor Centre of Inflammation and Metabolism
  More Information

No publications provided

Responsible Party: Inge Holm, Administrator, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01376583     History of Changes
Other Study ID Numbers: VEK-H-3-2010-141
Study First Received: June 16, 2011
Last Updated: November 28, 2013
Health Authority: Denmark: Ethics Committee

Keywords provided by Rigshospitalet, Denmark:
Breast cancer
Exercise
Myokines
AMPK

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on April 17, 2014